176 results on '"Volz, Yannic"'
Search Results
2. The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study
3. The effect of hospital caseload on perioperative mortality, morbidity and costs in bladder cancer patients undergoing radical cystectomy: results of the German nationwide inpatient data
4. Häufige Fehler, „Pitfalls“ und Komplikationsmanagement der Prostatabiopsie: Die häufigsten diagnostischen und prozeduralen Herausforderungen der transrektalen Fusionsbiopsie der Prostata bei Erstdiagnose eines klinisch signifikanten Prostatakarzinoms
5. Transrektale vs. transperineale Fusionsbiopsie der Prostata: Zeit für einen Wechsel zur perinealen Technik – Vergleich der Methoden und Beschreibung des transperinealen operativen Vorgehens in Lokalanästhesie
6. Standard operating procedure to reveal prostate cancer specific volatile organic molecules by infrared spectroscopy
7. Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer—An Extensive Multiregional Immunohistochemical Analysis
8. Asymptomatic bacteriospermia and infertility—what is the connection?
9. Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer
10. Trends and outcomes of hospitalized patients with priapism in Germany: results from the GRAND study
11. The prognostic value of perioperative platelet and leukocyte values in patients undergoing radical cystectomy: a prospective long-term cohort study
12. PD46-10 PERIOPERATIVE OUTCOMES AND EVOLUTION OF PENILE PROSTHESIS IMPLANTATION IN GERMANY: RESULTS FROM THE GRAND STUDY
13. PD38-11 IMPAIRMENT OF THE PATIENT’S HEALTH-RELATED QUALITY OF LIFE DUE TO A ORTHOTOPIC NEOBLADDER AFTER RADICAL CYSTECTOMY—DEFINING AN AGE-RELATED THRESHOLD
14. MP22-12 PROSPECTIVE EVALUATION OF OBJECTIVE VS. SUBJECTIVE GRADING OF COMPLICATIONS AFTER RADICAL CYSTECTOMY
15. MP72-13 THE IMPACT OF HEALTH CARE ON OUTCOMES OF SUSPECTED TESTICULAR TORSION: RESULTS FROM THE GRAND STUDY
16. MP22-15 THE USE OF PERIOPERATIVE OPIOIDS IS ONCOLOGICALLY SAFE IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER
17. Harnblasenkarzinom: Wann daran denken, wie diagnostizieren?
18. The COVID-19 pandemic — what have urologists learned?
19. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
20. Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis
21. Das Wichtigste zur Therapie des Harnblasenkarzinoms
22. Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
23. Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data Study.
24. Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort.
25. Added value of randomized biopsy to mpMRI‐targeted biopsy of the prostate in a contemporary cohort
26. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
27. Penile fractures: the price of a merry Christmas
28. Upstaging after TUR-BT for non-muscle invasive cancer of the bladder – Who is at highest risk?
29. Harnwegsinfekt: kompliziert oder unkompliziert?
30. Management der Prostatitis und bakteriellen Epididymitis
31. Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
32. Oncological impact of perioperative blood transfusion in bladder cancer patients undergoing radical cystectomy: Do we need to consider storage time of blood units, donor age, or gender matching?
33. mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
34. mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center
35. The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting
36. Absence of detrusor muscle in TUR-BT specimen – can we predict who is at highest risk?
37. Common errors, pitfalls, and management of complications of prostate biopsy
38. PD25-02 INTRATUMORAL HETEROGENEITY OF MOLECULAR SUBTYPES IN MUSCLE-INVASIVE BLADDER CANCER – AN EXTENSIVE MULTI-REGIONAL IMMUNOHISTOCHEMICAL ANALYSIS
39. MP34-19 PERIOPERATIVE AND LONG-TERM INFECTIOUS COMPLICATIONS AFTER RADICAL CYSTECTOMY: A PROSPECTIVE OBSERVATIONAL STUDY
40. Adverse Pathology after Radical Prostatectomy of Patients Eligible for Active Surveillance—A Summary 7 Years after Introducing mpMRI-Guided Biopsy in a Real-World Setting
41. Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder
42. MP03-05 HOW DOES THE TYPE OF URINARY DIVERSION AFFECT HEALTH RELATED QUALITY OF LIFE (HRQOL) IN THE COURSE OF FOUR YEARS AFTER RADICAL CYSTECTOMY? - A PROPENSITY SCORE-MATCHED ANALYSIS
43. MP22-10 HOW IS HEALTH-RELATED QUALITY OF LIFE AFFECTED BY SALVAGE CYSTECTOMY AND URINARY DIVERSION AS A LAST-LINE OPTION FOR BENIGN DISEASE
44. Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
45. Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy
46. Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy
47. The Burden of Fear of Cancer Recurrence in Genitourinary Cancers: A Prospective Study (NCT04535921)
48. Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
49. Impact of bacillus Calmette‐Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high‐grade bladder cancer
50. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.